Semprae Laboratories has been acquired by Innovus Pharmaceuticals, a provider of health solutions through over-the-counter medicines and consumer health products. Founded in 2008, Semprae provides products that aim to improve the sexual health of women. The company will add two of its products, Zestra and Zestra Glide, to Innovus' female sexual health product pipeline.
The acquired company, which has raised nearly $23 million in VC funding to date, brings a number of benefits to Innovus. Through its two products, Semprae adds about $1 million in new annual gross revenues, over 85,000 retail customers and an immediate presence in large U.S. retailers like Walmart, Target and Drugstore.com.